PTC Therapeutics PTCT Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's operating cash flow?
- PTC Therapeutics (PTCT) reported operating cash flow of -$59.04M in Q1 2026.
- How has PTC Therapeutics's operating cash flow changed year-over-year?
- PTC Therapeutics's operating cash flow decreased by 106.8% year-over-year, from $870.1M to -$59.04M.
- What is the long-term trend for PTC Therapeutics's operating cash flow?
- Over 3 years (2021 to 2024), PTC Therapeutics's operating cash flow has grown at a -24.6% compound annual growth rate (CAGR), from -$251.33M to -$107.69M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.